Jeff K.

Jeff K. serves as the Chief Operating Officer at Crinetics Pharmaceuticals since August 2021, with expertise in Project and Portfolio Management, Product Leadership and Strategy, and Clinical Operations among other areas. Previously, Jeff K. held senior positions at Poseida Therapeutics, Inc., overseeing Portfolio Management and Corporate Operations, and at Halozyme Therapeutics, Inc. as Vice President of Development Operations. A background in global operations at Amgen and Onyx Pharmaceuticals further solidified Jeff K.'s extensive experience in clinical and regulatory affairs. Education credentials include an MPH in Biostatistics and Epidemiology, a BSN in Nursing, and a BA in Psychology from reputable institutions.